Advertisement

TransMedics Inc., an Andover medical device company that develops organ transplant technologies, has raised $36 million in equity, according to federal filings.

The funding, which comes from 15 investors, comes a little more than a year after the company’s last fund raise of $6 million from nine investors, which was itself a little more than a year after the previous investment of $35 million from 26 investors. The company has now raised at least $166 million since it was founded in 1998 by CEO and President Waleed Hassanein.

Advertisement
Advertisement